Related Experiment Video
Updated: Jun 4, 2026
12:34
The Efficacy and Underlying Pathway Mechanisms of ShiDuGao Treatment for Anus Eczema Based on GEO Datasets and Network Pharmacology
Published on: January 12, 2024
iGEMDOCK: a graphical environment of enhancing GEMDOCK using pharmacological interactions and post-screening analysis
Kai-Cheng Hsu1, Yen-Fu Chen, Shen-Rong Lin
1Institute of Bioinformatics and Systems Biology, National Chiao Tung University, Hsinchu 30050, Taiwan.
BMC Bioinformatics
|February 24, 2011
Summary
We developed iGEMDOCK, an integrated virtual screening environment, to identify pharmacological interactions from screening compounds, aiding drug discovery and understanding ligand binding mechanisms.
Area of Science:
- Computational drug discovery
- Molecular modeling
- Bioinformatics
Background:
- Understanding ligand binding mechanisms is crucial for drug discovery.
- Traditional methods rely on experimental data for inferring interactions.
- Existing virtual screening (VS) programs often lack integration across different stages.
Purpose of the Study:
- To develop an integrated virtual screening environment (iGEMDOCK).
- To enable direct identification of pharmacological interactions from screening compounds.
- To facilitate drug discovery by improving VS workflows.
Main Methods:
- Development of iGEMDOCK, a user-friendly graphic environment.
- Integration of VS stages: preparation, screening, and post-screening analysis.
- Derivation of pharmacological interactions from screening compounds without experimental data.
Main Results:
- iGEMDOCK successfully integrates VS stages.
- Pharmacological interactions derived by iGEMDOCK represent conserved residues and hot spots.
- The tool provides visualizations of protein-compound interactions and compound clustering.
Conclusions:
- iGEMDOCK facilitates VS from target preparation to post-screening analysis.
- It is particularly useful for inferring pharmacological interactions and understanding binding mechanisms.
- iGEMDOCK aids in the discovery of lead compounds.
